Drug Interaction Study With Proton Pump Inhibitor

• Status: Completed
• Trial end date: 2006-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this clinical research study is to assess the effect of omeprazole at 20 mg on the pharmacokinetics of atazanavir administered as atazanavir with ritonavir relative to atazanavir or atazanavir/ritonavir in the absence of omeprazole in healthy subjects.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: Atazanavir Sulfate; Omeprazole; Proton Pump Inhibitors; Ritonavir

Criteria

Inclusion Criteria:

• Healthy male and female subjects between the ages of 18 to 50 years old with BMI 18 to 32 kg/m2